Silo PharmaSILO
13F holders, Q2 2024 (June 30)10holders
3new positions
4sold out
$0.99avg. 13F price*
At the end of Q2 2024, 10 institutions reported holding Silo Pharma Inc. (SILO) in their 13F filings, unchanged from Q1 2024. 3 opened new positions and 4 sold out. The largest holders were Virtu Financial LLC ($41K), Financial Advocates Investment Management ($24K) and Vanguard Group Inc. ($16K).
- Company
- Silo Pharma Inc.
- CUSIP
- 82711P201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $43K |
| Exits | 4 | $1.0M |
All 13F filers, Q1 2024 → Q2 2024: 46,096 shares bought and 39,340 shares sold, net +6,756 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Virtu Financial LLC | 0.00% | New | 41,848 | $41K |
| Financial Advocates Investment Management | 0.00% | Reduce -61.9% | 23,938 | $24K |
| Vanguard Group Inc. | 0.00% | No change | 16,334 | $16K |
| Geode Capital Management, LLC | 0.00% | No change | 16,179 | $16K |
| State Street Corp. | 0.00% | No change | 12,500 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +50.3% | 6,663 | $7K |
| Redwood Wealth Management Group, LLC | 0.00% | New | 2,000 | $2K |
| Westside Investment Management, Inc. | 0.00% | No change | 94 | $94 |
| Bank of America Corp. | 0.00% | New | 17 | $17 |
| JPMorgan Chase & Co. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is SILO's weight in each manager's 13F, not the share of Silo Pharma Inc. the manager owns.